• Visit the Adenoscan^® Web site for more information about this medication.
• View Adenoscan^® U.S. Physician Prescribing Information. (PDF - 320KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Adenocard^® Web site for more information about this medication.
• View Adenocard^® U.S. Physician Prescribing Information. (PDF - 117KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Lexiscan^® Web site for more information about this medication.
• View Lexiscan^® U.S. Physician Prescribing Information. (PDF - 154KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Vaprisol^® Web site for more information about this medication.
• View Vaprisol^® U.S. Physician Prescribing Information. (PDF - 499KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Protopic^® Web site for more information about this medication.
• View Protopic^® U.S. Physician Prescribing Information. (PDF - 134KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Prograf^® Web site for more information about this medication.
• View Prograf^® U.S. Physician Prescribing Information. (PDF - 246KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the AmBisome^® Web site for more information about this medication.
• View AmBisome^® U.S. Physician Prescribing Information. (PDF - 499KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the MYCAMINE^® Web site for more information about this medication.
• View MYCAMINE^® U.S. Physician Prescribing Information. (PDF - 259KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

• Visit the Vibativ^® Web site for more information about this medication.
• View Vibativ^® U.S. Physician Prescribing Information. (PDF - 185KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)

On January 6, 2012, Astellas Pharma Inc. and Theravance, Inc. announced that Astellas has exercised its right to terminate the global License, Development and Commercialization Agreement for VIBATIV^® (telavancin) for injection. The rights granted to Astellas ceased upon termination of the Agreement and Astellas has stopped promotional sales efforts.

• Visit the SUMAVEL^TM DosePro^TM (sumatriptan injection) Needle-free delivery system Web site for more information about this medication.
• View the SUMAVEL^TM DosePro^TM (sumatriptan injection) Needle-free delivery system U.S. Physician Prescribing Information. (PDF - 456KB)

• Visit the Tarceva^® Web site for more information about this medication.
• View Tarceva^® U.S. Physician Prescribing Information. (PDF - 19KB)

• Visit the VESIcare^® Web site for more information about this medication.
• View VESIcare^® U.S. Physician Prescribing Information. (PDF - 134KB)
• Return Goods Policy:
  • Physicians and Non-Hospital Clinics. (PDF - 26KB)
  • Wholesalers/Distributors, Pharmacies, Hospitals. (PDF - 34KB)